The future of medicine grows from understanding its past, and Pennsylvania Hospital’s museum brings that history to life in a milestone anniversary year.
Using organoids as models of human brains and brain cancer, Hongjun Song, PhD, and Guo-li Ming, MD, PhD, are making major scientific advances together.
Julia Puchtler will lead Penn Medicine’s financial strategy and help shape long-term investments in patient care, research, and education.
The gift establishes the Middleman Center and Middleman Fund to advance promising discoveries and speed new treatments to patients.
“Every kid can do science.” That’s the mission of Jamie Shuda, who has expanded Penn Medicine’s STEM community outreach programs.
As vaccine-preventable illnesses re-emerge, Penn Medicine is prepared—and committed to keeping patients, staff, and communities healthy and safe.
The new form of proton therapy is called FLASH and is designed to deliver cancer-killing radiation therapy in less than a second.
The original structure of the nation’s first chartered hospital—home to early mental health and maternity care—is a living symbol of innovation.
Stacey Peeples oversees the archives of the nation’s first chartered hospital, home to a nearly three-hundred-year collection of medical artifacts.
At Pennsylvania Hospital, tracing the history of the apothecary shows the importance of professionals helping patients with medicines, then and now.
Dennis Massimo was only 42 and symptom-free when he was diagnosed with colorectal cancer related to an inherited condition he didn’t realize he had.
The Clyde F. Barker Penn Transplant House offers a comforting and affordable refuge for transplant patients and families—with community and hope.
A program where cancer patients can get free mental health care addresses an underrecognized need: that cancer’s deepest wounds are often not physical.
The pharmacy system of the future is here at Penn Medicine: a powerful union of advanced tech with human expertise, improving patients’ health.
A new initiative frees Penn primary care doctors from most on-call duties after work hours, while patients still have 24-hour access to virtual care.
Simulations and test runs helped Penn Medicine teams prepare for the launch of a Hospital at Home program at two of the system’s hospitals.
Jean Bennett, Albert Maguire, and Kathy High honored for trailblazing work on the first FDA-approved gene therapy for an inherited condition.
A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes.
In a historic medical breakthrough, a child with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy.
The science of cancer interception is advancing at Penn Medicine with a new platform to develop cancer vaccines piling scientific strength upon strength.
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.
The Basser Center for BRCA is running an innovative cancer interception clinical trial that depends on volunteers with deep, personal ties to cancer.
The Gambles’ generosity helped hundreds of students attend medical school at Penn tuition-free since 1992, and today’s alumni continue to grow their vision.
Through the Basser Center for BRCA Postdoctoral Fellowship Program, the Sands are cultivating the next generation of discovery to intercept cancer.
A reimagined facility has been introduced as the epicenter for pioneering Penn research aimed at “breaking the immunological code” of autoimmune diseases and bringing them to heel.
A muscle science lab draws on personal experience at the extremes—world-class athleticism and muscular dystrophy—in seeking a safer gene therapy.
Even before she experienced cancer herself, Deborah Burnham, PhD, had a knack for “magical” prompts to help cancer patients write through their illness.
At home and overseas, Florencia Polite, MD, is on a mission to help patients and physicians understand how RSV vaccines protect newborns.
Medical students face a gauntlet of travel for interviews before their match—but Penn alumni mentors help out at this and other key career stages.
The gift sparks curriculum transformation, new lectureship, and names Entrepreneurship Pathway in honor of alumnus Rod Wong, M03.
Penn Medicine is leveraging emerging technology to strengthen clinical reasoning skills and patient care among medical students and residents.
Researchers are capturing images of the biology inside our cells using cryogenic electron microscopy to inform how we understand and treat disease.
Penn is at the forefront of using close-up imaging techniques to suggest new ways to match drugs to biological receptors like a key with a lock.
Understanding how a disease starts and gets going is essential to finding treatments—and imaging with cryoEM and cryoET is leading to such insights.
Penn Medicine is building better systems that help patients build health care around their lives instead of their lives around health care.
Penn Medicine research is bringing the “sleeper” phase of cancer to light—creating hope that more cancers could be wiped out for good and never come back.
Reversing racial inequities is a full-force effort rooted in research that includes gardens and parks, financial support, and lifting up local community members.
